Relationship of C-reactive protein to insulin resistance and metabolic syndrome

CLINICAL FOCUS ›› 2006, Vol. 21 ›› Issue (20): 1464-1467.

Previous Articles Next Articles

Relationship of C-reactive protein to insulin resistance and metabolic syndrome

SONG Xiu-xia;JIANG Tao

Online:2006-10-20 Published:2006-10-20

Abstract

CLC Number:

R587.1

SONG Xiu-xia;JIANG Tao. Relationship of C-reactive protein to insulin resistance and metabolic syndrome[J]. CLINICAL FOCUS, 2006, 21(20): 1464-1467.

Add to citation manager EndNote|Ris|BibTeX

URL: http://www.lchc.cn/EN/

http://www.lchc.cn/EN/Y2006/V21/I20/1464

[1]	Xiao Ke, Wang Qi. Clinical characteristics and risk factor analysis of type 2 diabetes mellitus complicated with cryptococcal meningitis [J]. Clinical Focus, 2025, 40(5): 423-427.
[2]	Ju Panyu, Yang Fuqi, Zhou Xingjian. Study on the association between triglyceride-glucose and thyroid nodules in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2025, 40(4): 329-333.
[3]	Hu Songlin, Di Ya, Liu Canzhang, Yan Jie. Study on the relationship between platelet/lymphocyte ratio and coronary plaque characteristics in coronary heart disease patients combined with type 2 diabetes mellitus by virtual histology intravascular ultrasound [J]. Clinical Focus, 2025, 40(2): 117-121.
[4]	Shi Shuangwei, Rao Xiaojuan, Xie Liran, Fang Yifan, Wang Shanshan. Correlation between thyroid hormone sensitivity and non-alcoholic fatty liver in type 2 diabetes mellitus patients with normal thyroid function [J]. Clinical Focus, 2025, 40(2): 133-137.
[5]	Liang Yi. Meta-analysis of effects of curcumin on inflammation and oxidative stress of patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(11): 974-979.
[6]	Shi Shasha, Ren Haotian, Song Lifei, Li Jiani, Zhou Yan, Zhang Yan. Summaries from best evidence in brief for management of hyperglycemia after enteral nutrition in patients with severe stroke [J]. Clinical Focus, 2024, 39(11): 1000-1006.
[7]	Wang Jing, Li Caige, Wang Ting, Liu Zibo, Gai Bin, Jin Yangyu, Zhang Lihui. Efficacy of empagliflozin combined with liraglutide on obese and overweight T2DM patients and its impact on inflammatory factors: A prospective, randomized, open-label, parallel-controlled clinical study [J]. Clinical Focus, 2024, 39(10): 909-914.
[8]	Li Jiawen, Liu Yanlan, Li Yaoshuang, Qiu Huina, Li Fang, Wu Fan, Lin Chenying, Lin Jingna. Association of TyG index and its derivatives with the risk of diabetic kidney disease in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(10): 901-908.
[9]	Ma Jiannan, Tao Jie, Sang Dasen, Wu Shouling, Zhang Qi. Association of urinary transferrin with new-onset cardiovascular disease in type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(8): 700-705.
[10]	Xiong Lu, Guo Lian. Correlation of 25(OH)D and SUA/SCr with type 2 diabetes mellitus combined with non-alcoholic fatty liver disease [J]. Clinical Focus, 2024, 39(8): 706-711.
[11]	. [J]. Clinical Focus, 2024, 39(8): 758-762.
[12]	. [J]. Clinical Focus, 2024, 39(7): 650-653.
[13]	Yue Jianghong, Wang Heng, Cai Gang, Zhang Xuanming, Peng Xi. Efficacy and safety of sotagliflozin in the treatment of type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2024, 39(7): 581-592.
[14]	Du Sina, Li Wei, Lin Yajing, Sun Jianguo, Mao Mao, Chen Jianwei, Sun Danbo, Mao Yushan. Application of insulin dose spectrum after an intensive insulin pump therapy in type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(7): 620-624.
[15]	Sun Hui, Liu Haiying, Ren Junhao, Li Jinxia. Bidirectional Mendelian randomization study of causality between body mass index and type 2 diabetes in a European population [J]. Clinical Focus, 2024, 39(4): 325-331.

Relationship of C-reactive protein to insulin resistance and metabolic syndrome

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments